🔗 Visit the ClinicalTrials.gov page for NCT00314262
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. | Clin Cancer Res | 2013 | 1.02 |
| 2 | Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. | Br J Cancer | 2013 | 0.86 |
| 3 | Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling. | Oral Oncol | 2013 | 0.81 |